H.R. 4553 · 116th Congress
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
- Stage
- In committee
- Sponsor
- Brendan Boyle
- Introduced
- 2019-09-27
- Latest action
- 2019-09-30 · Referred to the Subcommittee on Health.
Summary
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.